Evidence map›Paper›PMID 39235934›Full record

ArticleJournal of the National Cancer Institute2025

Understanding risk factors for endometrial cancer in young women.

Noah Charles Peeri, Kimberly A Bertrand, Renhua Na, Immaculata De Vivo, Veronica Wendy Setiawan, Venkatraman E Seshan, Laia Alemany, Yu Chen, Megan A Clarke, Tess Clendenen and 39 more

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Fertility-Sparing Treatment of Endometrial Cancer: Survey of Australian Practice.The Australian & New Zealand journal of obstetrics & gynaecology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors.

Noah Charles PeeriEpidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-4278-650X
Kimberly A BertrandSlone Epidemiology Center and Department of Medicine, Boston University, Boston, MA, USA.
Renhua NaPopulation Health Program, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Herston, Qld, Australia.
Immaculata De VivoDepartment of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Veronica Wendy SetiawanPreventive Medicine, University of Southern California, Los Angeles, CA, USA.
Venkatraman E SeshanEpidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-9258-2698
Laia AlemanyCancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain.
Yu ChenPopulation Health, Epidemiology, NYU Grossman School of Medicine, New York, NY, USA.
Megan A ClarkeClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Tess ClendenenPopulation Health, Epidemiology, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0003-4170-6977
Linda S CookDepartment of Epidemiology, University of Colorado-Anschutz, Aurora, CO, USA.
Laura CostasCancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain.
Luigino Dal MasoCancer Epidemiology, Centro di Riferimento Oncologico di Aviano Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy.ORCID 0000-0001-6163-200X
Jo L FreudenheimEpidemiology and Environmental Health, University at Buffalo, Buffalo, NY, USA.ORCID 0000-0002-9301-0499
Christine M FriedenreichCancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada.
Gretchen L GierachIntegrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0002-0165-5522
Marc T GoodmanMedicine, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Carlo La VecchiaDepartment of Clinical Medicine and Community Health, Università degli Studi di Milano, Milan, Italy.
Fabio LeviDepartment of Epidemiology and Health Services Research (Unisanté), University of Lausanne, Lausanne, Switzerland.
Marta Lopez-QuerolCancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute, Barcelona, Spain.
Lingeng LuChronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.ORCID 0000-0001-9871-0809
Kirsten B MoysichCancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
George MutterBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Jeffin NaduparambilEpidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Eva NegriDepartment of Medical and Surgical Sciences, Università di Bologna, Bologna, Italy.
Kelli O'ConnellEpidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0002-4021-0788
Tracy O'MaraCancer Research Program, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
Julie R PalmerSlone Epidemiology Center and Department of Medicine, Boston University, Boston, MA, USA.
Fabio ParazziniDepartment of Clinical Medicine and Community Health, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0001-5624-4854
Kathryn Lee PenneyDepartment of Epidemiology, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Stacey PetruzellaEpidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Peggy ReynoldsDepartment of Epidemiology and Biostatistics, University of California San Francisco, Berkeley, CA, USA.
Fulvio RicceriCentre for Biostatistics, Epidemiology, and Public Health, Department of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy.ORCID 0000-0001-8749-9737
Harvey RischChronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.ORCID 0000-0001-5337-3941
Thomas E RohanEpidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Turin, Italy.ORCID 0000-0002-8008-5096
Sven SandinDepartment of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0001-6994-4884
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Rachael Z Stolzenberg-SolomonMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Penelope M WebbPopulation Health Program, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Herston, Qld, Australia.
Nicolas WentzensenClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.ORCID 0000-0003-1251-0836
Lynne R WilkensEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.ORCID 0000-0001-8408-4536
Wanghong XuEpidemiology, Fudan University, School of Public Health, Shanghai, China.
Herbert YuEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Anne Zeleniuch-JacquottePopulation Health, Epidemiology, NYU Grossman School of Medicine, New York, NY, USA.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Xingyi GuoDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0001-5269-1294
Loren LipworthDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Mengmeng DuEpidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-6156-1491

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI FRANCESCA M GANY · 1985 to 2026
$347.4M
Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Cheongeun Oh · 1985 to 2026
$83.1M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GORDON, TERRY · 1985 to 2020
$26.1M
A Follow-up Study for Causes of Cancer in Black WomenU01CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Kimberly A. Bertrand, Yvette C Cozier · 2017 to 2026
$24.0M
Southern Community Cohort StudyU01CA202979 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLOT, WILLIAM J., SHRUBSOLE, MARTHA J. · 2016 to 2025
$22.0M
FOLLOW-UP STUDY FOR CAUSES OF ILLNESS IN BLACK WOMENR01CA058420 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENBERG, LYNN · 1999 to 2013
$20.7M
Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparitiesU01CA250476 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Immaculata De Vivo, Mengmeng Du · 2021 to 2026
$5.2M
The NYU Women's Health StudyU01CA182934 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHEN, YU · 2020 to 2023
$2.7M
Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS)T32CA275764 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONINE L. BERNSTEIN, JUN J MAO · 2023 to 2026
$1.8M
Estrogen Metabolism Related Genes &Endometrial CancerR01CA081212 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELENIUCH-JACQUOTTE, ANNE · 1999 to 2007
$995k
Endometrial cancer in black womenR03CA169888 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WISE, LAUREN A · 2013 to 2014
$123k
Alberta Endometrial Cancer Case-control StudyAlberta Heritage Foundation for Medical ResearchArmy Medical Research Program DAMD 17-96-607Bay Area Women's Health StudyBlack Womens' Health Study R01CA058420Boston University Medical Campus Institutional Review BoardBreast Cancer Detection DemonstrationCalifornia Breast Cancer Research 4JB-1106Canada Research ChairCanadian Cancer SocietyCancer Council Tasmania 403031Carlos III Health Institute PI19/01835Centers for Disease Control and Prevention'sCIHREpidemiology of Endometrial Cancer ConsortiumEuropean Regional Development FundHHSMemorial Sloan Kettering Cancer CenterNational Cancer Institute's Surveillance, Epidemiology, and End ResultsNational Health and Medical Research Council APP339435National Program of Cancer RegistriesNCINCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016056NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA058420NCI NIH HHS R01 CA081212NCI NIH HHS R03 CA169888NCI NIH HHS T32 CA275764NCI NIH HHS U01 CA164974NCI NIH HHS U01 CA182934NCI NIH HHS U01 CA202979NCI NIH HHS U01 CA250476New York University Womens' Health StudyNIEHS NIH HHS P30 ES000260NIHNIH HHSNIH HHS R01 CA74877Roswell Park Cancer Institute Patient Epidemiological Data System P30CA016056Southern Community Cohort Study U01CA202979Swedish Research Council 521-2011-2955Swiss National Cancer Research Foundation OCS 1633-02-2005Swiss National Science Foundation 32.9495.88The Australian National Endometrial Cancer Study GroupThe E2C2 Data Coordinating CenterWestern New York Diet Study P30CA016056Womens' Lifestyle and Health Study
6 · The paper itself

Abstract

backgroundThe American Cancer Society recommends physicians inform average-risk women about endometrial cancer risk on reaching menopause, but new diagnoses are rising fastest in women aged younger than 50 years. Educating these younger women about endometrial cancer risks requires knowledge of risk factors. However, endometrial cancer in young women is rare and challenging to study in single study populations.

methodsWe included 13 846 incident endometrial cancer patients (1639 aged younger than 50 years) and 30 569 matched control individuals from the Epidemiology of Endometrial Cancer Consortium. We used generalized linear models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for 6 risk factors and endometrial cancer risk. We created a risk score to evaluate the combined associations and population attributable fractions for these factors.

resultsIn younger and older women, we observed positive associations with body mass index and diabetes and inverse associations with age at menarche, oral contraceptive use, and parity. Current smoking was associated with reduced risk only in women aged 50 years and older (Phet < .01). Body mass index was the strongest risk factor (OR≥35 vs<25 kg/m2 = 5.57, 95% CI = 4.33 to 7.16, for ages younger than 50 years; OR≥35 vs<25 kg/m2 = 4.68, 95% CI = 4.30 to 5.09, for ages 50 years and older; Phet = .14). Possessing at least 4 risk factors was associated with approximately ninefold increased risk in women aged younger than 50 years and approximately fourfold increased risk in women aged 50 years and older (Phet < .01). Together, 59.1% of endometrial cancer in women aged younger than 50 years and 55.6% in women aged 50 years and older were attributable to these factors.

conclusionsOur data confirm younger and older women share common endometrial cancer risk factors. Early educational efforts centered on these factors may help mitigate the rising endometrial cancer burden in young women.

Indexed as

Body Mass IndexEndometrial NeoplasmsAdultAgedAge FactorsCase-Control StudiesContraceptives, OralDiabetes MellitusFemaleHumansMenarcheMiddle AgedOdds RatioParityRisk FactorsSmokingContraceptives, Oral

Identifiers

PMID39235934
PMCPMC11717423

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.